Carregant...
Validation of a care pathway for the use of faecal calprotectin in monitoring patients with Crohn's disease
INTRODUCTION: We have previously published an evidence-based care pathway for the use of faecal calprotectin (FC) to monitor patients with Crohn's disease established on therapy. Patients are treated as low, intermediate or high risk of continuing Crohn's disease activity based on their FC...
Guardat en:
| Publicat a: | Frontline Gastroenterol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5558279/ https://ncbi.nlm.nih.gov/pubmed/28839907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2016-100780 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|